11:00Chronic Hypertension: A Neglected Condition but With Emerging Importance in Obstetrics and Beyond -
Justin S. Brandt Cande V. Ananth Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NYU Langone Health, New York, NY (J.S.B.). Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences; Cardiovascular Institute of New Jersey; and Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (C.V.A.). Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ (C.V.A.).
Hypertension
Hypertension, Ahead of Print. (Hypertension)
11:00Chronic Hypertension During Pregnancy: Prevalence and Treatment in the United States, 2008–2021 -
Stephanie A. Leonard Sara Siadat Elliott K. Main Krista F. Huybrechts Yasser Y. El-Sayed Mark A. Hlatky Jheanelle Atkinson Ayesha Sujan Brian T. Bateman Department of Obstetrics and Gynecology, Stanford University School of Medicine, CA. (S.A.L., E.K.M., Y.Y.E.-S.) Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, CA. (S.S., A.S., B.T.B.) Departments of Health Policy and Medicine, Stanford University School of Medicine, CA. (M.A.H.) Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s (…)
Hypertension
Hypertension, Ahead of Print. BACKGROUND:Treatment of chronic hypertension during pregnancy has been shown to reduce the risk of adverse perinatal outcomes. In this study, we examined the prevalence and treatment of chronic hypertension during pregnancy and assessed changes in these outcomes (…) (Hypertension)
11:00Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults -
Kendra D. Sims Pengxiao Carol Wei Joanne M. Penko Susan Hennessy Pamela G. Coxson Nita H. Mukand Brandon K. Bellows Dhruv S. Kazi Yiyi Zhang Ross Boylan Andrew E. Moran Kirsten Bibbins-Domingo Department of Epidemiology and Biostatistics, University of California San Francisco (K.D.S., P.C.W., J.M.P., S.H., P.G.C., N.H.M., R.B., K.B.-D.). Department of Epidemiology, Boston University School of Public Health, MA (K.D.S.). Department of Medicine, Division of General Medicine, Columbia University Irving Medical Center, New York, NY (B.K.B., Y.Z., A.E.M.). Richard A. and Susan F. Smith Center (…)
Hypertension
Hypertension, Ahead of Print. BACKGROUND:The 2017 American College of Cardiology/American Heart Association blood pressure guideline classified 31 million US adults as having stage 1 hypertension and recommended clinicians provide counseling on behavioral change to the low-risk portion of this (…) (Hypertension)
11:00Immune Mechanisms in Hypertension -
David G. Harrison David M. Patrick Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (D.G.H., D.M.P.). Department of Veterans Affairs, Nashville, TN (D.M.P.).
Hypertension
Hypertension, Ahead of Print. It is now apparent that immune mediators including complement, cytokines, and cells of the innate and adaptive immune system contribute not only to blood pressure elevation but also to the target organ damage that occurs in response to stimuli like high salt, (…) (Hypertension)
11:00Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINT -
Saeid Mirzai Ian Persits Richard Kazibwe Mohanad Gabani Austin Seals Matthew J. Singleton Rishi Rikhi Parag Chevli Salvatore Carbone W.H. Wilson Tang Joseph Yeboah Jeff D. Williamson Dalane W. Kitzman David Herrington Michael D. Shapiro Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC. (S.M., M.G., A.S., R.R., J.Y., D.W.K., D.H., M.D.S.) Section on Hospital Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC. (R.K., P.C.) Section on Gerontology and Geriatric (…)
Hypertension
Hypertension, Ahead of Print. BACKGROUND:Sarcopenia and hypertension are independently associated with worse cardiovascular disease (CVD) risk and survival. While individuals with sarcopenia may benefit from intensive blood pressure (BP) control, the increased vulnerability of this population (…) (Hypertension)